...
首页> 外文期刊>British journal of biomedical science >Overexpression of long non-coding RNA MCM3AP-AS1 in breast cancer tissues compared to adjacent non-tumour tissues
【24h】

Overexpression of long non-coding RNA MCM3AP-AS1 in breast cancer tissues compared to adjacent non-tumour tissues

机译:与相邻的非肿瘤组织相比,乳腺癌组织中长的非编码RNA MCM3AP-AS1的过度表达

获取原文
获取原文并翻译 | 示例
           

摘要

Background Altered expression of several long non-coding RNAs (lncRNAs) has been described in numerous malignancies, including breast cancer, and some may have a role in carcinogenesis. We hypothesised differences in the expression of lncRNA MCM3AP-AS1 in breast cancer tissues compared to nearby healthy tissues and potential links with clinical features. Methods We tested our hypothesis in 102 pairs of breast cancer tumours and adjacent non-tumour tissues from female patients. After RNA extraction, cDNA synthesis was performed for all specimens. The differential gene expression was assessed using Quantitative Real-Time PCR Technique. Results There was a significant overexpression of the lncRNAs in tumour tissues as compared with their adjacent non-tumour tissues (P< 0.001). Expression was significantly linked with the tumour oestrogen receptor expression (P= 0.023) and tumour progesterone receptor expression (P< 0.001). ROC analysis showed an AUC of 0.67 (95% CI 0.60-0.75) (P< 0.001) with sensitivity and specificity of 58% and 76%, respectively Conclusion The lncRNA MCM3AP-AS1 may be a novel breast cancer lncRNA with high expression levels in breast cancer patients' tissue. Further investigations are needed to confirm its uses as a potential molecular marker and therapeutic target.
机译:背景:在包括乳腺癌在内的许多恶性肿瘤中,已经描述了几种长非编码RNA(lncRNAs)的表达改变,其中一些可能在癌变中起作用。我们假设与附近健康组织相比,乳腺癌组织中lncRNA MCM3AP-AS1的表达存在差异,并且可能与临床特征有关。方法我们在102对女性乳腺癌肿瘤和癌旁非肿瘤组织中检验了我们的假设。提取RNA后,对所有标本进行cDNA合成。利用实时定量PCR技术评估差异基因表达。结果lncRNAs在肿瘤组织中的表达明显高于癌旁组织(P<0.001)。表达与肿瘤雌激素受体表达(P=0.023)和肿瘤孕激素受体表达(P<0.001)显著相关。ROC分析显示AUC为0.67(95%CI为0.60-0.75)(P<0.001),敏感性和特异性分别为58%和76%。结论lncRNA MCM3AP-AS1可能是一种在乳腺癌患者组织中高表达的新型乳腺癌lncRNA。需要进一步研究以确认其作为潜在的分子标记物和治疗靶点的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号